NCT03077828 2023-06-02
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Northwestern University
Phase 2 Unknown
Northwestern University
St. Petersburg State Pavlov Medical University
Istituto Clinico Humanitas